Search research articles
Contact Us
Filters
Showing results (371-380 of 607) with videos related to
Page
of 61
Sort By:
The European Respiratory Journal
|
June 23, 2009
Multiplex immune serum biomarker profiling in sarcoidosis and systemic sclerosis
P Beirne, P Pantelidis, P Charles, et al.
Seminars in Arthritis and Rheumatism
|
June 8, 2024
COVID-19 vaccinations and infections among individuals with systemic sclerosis: A Scleroderma Patient-centered Intervention Network (SPIN) Cohort study
Kimberly S Lakin, Yin Wu, Jessica K Gordon, et al.
JCI Insight
|
April 23, 2024
NKX2-5 regulates vessel remodeling in scleroderma-associated pulmonary arterial hypertension
Ioannis Papaioannou, Athina Dritsoula, Ping Kang, et al.
The American Journal of Pathology
|
December 7, 2006
Platelet-derived growth factor-beta receptor activation is essential for fibroblast and pericyte recruitment during cutaneous wound healing
Vineeth S Rajkumar, Xu Shiwen, Maria Bostrom, et al.
Rheumatology (Oxford, England)
|
August 22, 2006
Need for improved outcome measures in pulmonary arterial hypertension related to systemic sclerosis
O Distler, F Behrens, D Huscher, et al.
Rheumatology (Oxford, England)
|
November 3, 2016
Resolution of paraneoplastic PM/Scl-positive systemic sclerosis after curative resection of a pancreatic tumour
Cosimo Bruni, Ana Lages, Hitesh Patel, et al.
The Journal of Biological Chemistry
|
April 23, 2003
Fibroblast-specific expression of a kinase-deficient type II transforming growth factor beta (TGFbeta) receptor leads to paradoxical activation of TGFbeta signaling pathways with fibrosis in transgenic mice
Christopher P Denton, Bing Zheng, Lowri A Evans, et al.
Arthritis and Rheumatism
|
May 29, 2007
Bronchoalveolar lavage cellular profiles in patients with systemic sclerosis-associated interstitial lung disease are not predictive of disease progression
Nicole S L Goh, Srihari Veeraraghavan, Sujal R Desai, et al.
Annals of the Rheumatic Diseases
|
September 11, 2008
An open-label pilot study of infliximab therapy in diffuse cutaneous systemic sclerosis
C P Denton, M Engelhart, N Tvede, et al.
Rheumatology (Oxford, England)
|
September 16, 2022
Extent of fibrosis and lung function decline in patients with systemic sclerosis and interstitial lung disease: data from the SENSCIS trial
Christopher P Denton, Nicole S Goh, Stephen M Humphries, et al.
Page
of 61
Search research articles
Search
Showing results (371-380 of 607) with videos related to
Sort By:
Page
of 61
The European Respiratory Journal
|
June 23, 2009
Multiplex immune serum biomarker profiling in sarcoidosis and systemic sclerosis
P Beirne, P Pantelidis, P Charles, et al.
Seminars in Arthritis and Rheumatism
|
June 8, 2024
COVID-19 vaccinations and infections among individuals with systemic sclerosis: A Scleroderma Patient-centered Intervention Network (SPIN) Cohort study
Kimberly S Lakin, Yin Wu, Jessica K Gordon, et al.
JCI Insight
|
April 23, 2024
NKX2-5 regulates vessel remodeling in scleroderma-associated pulmonary arterial hypertension
Ioannis Papaioannou, Athina Dritsoula, Ping Kang, et al.
The American Journal of Pathology
|
December 7, 2006
Platelet-derived growth factor-beta receptor activation is essential for fibroblast and pericyte recruitment during cutaneous wound healing
Vineeth S Rajkumar, Xu Shiwen, Maria Bostrom, et al.
Rheumatology (Oxford, England)
|
August 22, 2006
Need for improved outcome measures in pulmonary arterial hypertension related to systemic sclerosis
O Distler, F Behrens, D Huscher, et al.
Rheumatology (Oxford, England)
|
November 3, 2016
Resolution of paraneoplastic PM/Scl-positive systemic sclerosis after curative resection of a pancreatic tumour
Cosimo Bruni, Ana Lages, Hitesh Patel, et al.
The Journal of Biological Chemistry
|
April 23, 2003
Fibroblast-specific expression of a kinase-deficient type II transforming growth factor beta (TGFbeta) receptor leads to paradoxical activation of TGFbeta signaling pathways with fibrosis in transgenic mice
Christopher P Denton, Bing Zheng, Lowri A Evans, et al.
Arthritis and Rheumatism
|
May 29, 2007
Bronchoalveolar lavage cellular profiles in patients with systemic sclerosis-associated interstitial lung disease are not predictive of disease progression
Nicole S L Goh, Srihari Veeraraghavan, Sujal R Desai, et al.
Annals of the Rheumatic Diseases
|
September 11, 2008
An open-label pilot study of infliximab therapy in diffuse cutaneous systemic sclerosis
C P Denton, M Engelhart, N Tvede, et al.
Rheumatology (Oxford, England)
|
September 16, 2022
Extent of fibrosis and lung function decline in patients with systemic sclerosis and interstitial lung disease: data from the SENSCIS trial
Christopher P Denton, Nicole S Goh, Stephen M Humphries, et al.
Page
of 61